Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Heron Therapeutics EPS - Earnings per Share 2010-2024 | HRTX

Heron Therapeutics eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  
Heron Therapeutics Annual EPS
2023 $-0.80
2022 $-1.67
2021 $-2.24
2020 $-2.50
2019 $-2.50
2018 $-2.44
2017 $-3.65
2016 $-4.56
2015 $-2.95
2014 $-2.87
2013 $-3.42
2012 $-1.91
2011 $-1.96
2010 $-3.80
2009 $-6.20
Heron Therapeutics Quarterly EPS
2024-03-31 $-0.02
2023-12-31 $-0.01
2023-09-30 $-0.17
2023-06-30 $-0.35
2023-03-31 $-0.27
2022-12-31 $-0.11
2022-09-30 $-0.38
2022-06-30 $-0.55
2022-03-31 $-0.63
2021-12-31 $-0.53
2021-09-30 $-0.51
2021-06-30 $-0.62
2021-03-31 $-0.58
2020-12-31 $-0.68
2020-09-30 $-0.64
2020-06-30 $-0.61
2020-03-31 $-0.57
2019-12-31 $-0.65
2019-09-30 $-0.42
2019-06-30 $-0.63
2019-03-31 $-0.80
2018-12-31 $-0.60
2018-09-30 $-0.49
2018-06-30 $-0.54
2018-03-31 $-0.81
2017-12-31 $-1.08
2017-09-30 $-0.77
2017-06-30 $-0.80
2017-03-31 $-1.00
2016-12-31 $-1.23
2016-09-30 $-1.24
2016-06-30 $-1.17
2016-03-31 $-0.92
2015-12-31 $-0.88
2015-09-30 $-0.63
2015-06-30 $-0.74
2015-03-31 $-0.70
2014-12-31 $-0.69
2014-09-30 $-0.66
2014-06-30 $-0.78
2014-03-31 $-0.74
2013-12-31 $-0.72
2013-09-30 $-0.84
2013-06-30 $-1.01
2013-03-31 $-0.85
2012-12-31 $-0.71
2012-09-30 $-0.40
2012-06-30 $-0.40
2012-03-31 $-0.40
2011-12-31 $0.24
2011-09-30 $-0.40
2011-06-30 $-1.00
2011-03-31 $-0.80
2010-12-31 $-1.00
2010-09-30 $-0.80
2010-06-30 $-1.80
2010-03-31 $-0.20
2009-12-31 $-0.80
2009-09-30 $-0.80
2009-06-30 $-2.60
2009-03-31 $-2.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.417B $0.127B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.132B 31.36
Chugai Pharmaceutical (CHGCY) Japan $51.893B 23.20
Takeda Pharmaceutical (TAK) Japan $41.934B 8.49
Merck (MKGAF) Germany $21.758B 20.53
Astellas Pharma (ALPMY) Japan $17.590B 27.77
Sandoz Group AG (SDZNY) Switzerland $15.507B 0.00
Shionogi (SGIOY) Japan $14.163B 12.70
Neurocrine Biosciences (NBIX) United States $13.757B 37.66
United Therapeutics (UTHR) United States $11.722B 12.50
Catalent (CTLT) United States $10.100B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.661B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.911B 7.60
Revolution Medicines (RVMD) United States $6.146B 0.00
Ionis Pharmaceuticals (IONS) United States $5.704B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.374B 0.00
Alpine Immune Sciences (ALPN) United States $4.257B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.780B 0.00
Summit Therapeutics (SMMT) United States $3.264B 0.00
Corcept Therapeutics (CORT) United States $2.815B 25.51
Arrowhead Pharmaceuticals (ARWR) United States $2.736B 0.00
PTC Therapeutics (PTCT) United States $2.473B 0.00
Indivior (INDV) United States $2.445B 11.59
Dyne Therapeutics (DYN) United States $2.272B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.045B 11.68
Recursion Pharmaceuticals (RXRX) United States $2.018B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.913B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.883B 18.32
Fusion Pharmaceuticals (FUSN) Canada $1.827B 0.00
Evotec AG (EVO) Germany $1.825B 0.00
Ardelyx (ARDX) United States $1.808B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.590B 27.83
Soleno Therapeutics (SLNO) United States $1.503B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.496B 0.00
Xencor (XNCR) United States $1.386B 0.00
Pacira BioSciences (PCRX) United States $1.369B 13.02
4D Molecular Therapeutics (FDMT) United States $1.315B 0.00
Enliven Therapeutics (ELVN) United States $1.101B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.098B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.096B 17.07
Cronos Group (CRON) Canada $1.058B 0.00
Collegium Pharmaceutical (COLL) United States $1.030B 6.16
Centessa Pharmaceuticals (CNTA) United Kingdom $0.904B 0.00
USANA Health Sciences (USNA) United States $0.890B 14.55
Ocular Therapeutix (OCUL) United States $0.877B 0.00
Cassava Sciences (SAVA) United States $0.875B 0.00
Relay Therapeutics (RLAY) United States $0.852B 0.00
ARS Pharmaceuticals (SPRY) United States $0.847B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.716B 0.00
Sage Therapeutics (SAGE) United States $0.716B 0.00
ProKidney (PROK) United States $0.644B 0.00
Savara (SVRA) United States $0.643B 0.00
Silence Therapeutics (SLN) United Kingdom $0.635B 0.00
Lyell Immunopharma (LYEL) United States $0.627B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.612B 0.00
Exscientia (EXAI) United Kingdom $0.557B 0.00
OmniAb (OABI) United States $0.548B 0.00
Siga Technologies (SIGA) United States $0.531B 6.78
Altimmune (ALT) United States $0.512B 0.00
KalVista Pharmaceuticals (KALV) United States $0.510B 0.00
Verve Therapeutics (VERV) United States $0.505B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.455B 0.00
Larimar Therapeutics (LRMR) United States $0.454B 0.00
Lexeo Therapeutics (LXEO) United States $0.433B 0.00
Bioventus (BVS) United States $0.428B 16.36
Esperion Therapeutics (ESPR) United States $0.415B 0.00
Harrow (HROW) United States $0.410B 0.00
Korro Bio (KRRO) United States $0.409B 0.00
Organogenesis (ORGO) United States $0.400B 75.75
Tourmaline Bio (TRML) United States $0.372B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.339B 0.00
Nektar Therapeutics (NKTR) United States $0.323B 0.00
Black Diamond Therapeutics (BDTX) United States $0.321B 0.00
Nanobiotix S.A (NBTX) France $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.308B 19.61
Fractyl Health (GUTS) United States $0.296B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
ESSA Pharma (EPIX) Canada $0.276B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.268B 0.00
Adherex Technologies (FENC) United States $0.266B 0.00
Xeris Biopharma Holdings (XERS) United States $0.261B 0.00
Pyxis Oncology (PYXS) United States $0.256B 0.00
Akebia Therapeutics (AKBA) United States $0.253B 0.00
Metagenomi (MGX) United States $0.245B 0.00
Foghorn Therapeutics (FHTX) United States $0.237B 0.00
Eliem Therapeutics (ELYM) United States $0.235B 0.00
Aldeyra Therapeutics (ALDX) United States $0.224B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.213B 0.00
Zevra Therapeutics (ZVRA) United States $0.209B 0.00
Telomir Pharmaceuticals (TELO) United States $0.205B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Acrivon Therapeutics (ACRV) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Galectin Therapeutics (GALT) United States $0.188B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.173B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Incannex Healthcare (IXHL) Australia $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.158B 0.00
Prelude Therapeutics (PRLD) United States $0.157B 0.00
Cardiol Therapeutics (CRDL) Canada $0.146B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.56
Regulus Therapeutics (RGLS) United States $0.145B 0.00
CytoDyn (CYDY) United States $0.145B 0.00
Context Therapeutics (CNTX) United States $0.140B 0.00
OptiNose (OPTN) United States $0.138B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
VAXART, INC (VXRT) United States $0.125B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.119B 7.98
FibroGen (FGEN) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.107B 0.00
PMV Pharmaceuticals (PMVP) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.100B 0.00
Inotiv (NOTV) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.091B 4.17
ProPhase Labs (PRPH) United States $0.091B 0.00
AlloVir (ALVR) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Jaguar Animal Health (JAGX) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.073B 1.03
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Protara Therapeutics (TARA) United States $0.062B 0.00
Carisma Therapeutics (CARM) United States $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
Nutriband (NTRB) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.036B 0.00
CASI Pharmaceuticals (CASI) China $0.036B 0.00
Surrozen (SRZN) United States $0.033B 0.00
DURECT (DRRX) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.020B 0.77
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
CERo Therapeutics Holdings (CERO) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Vivos Therapeutics (VVOS) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.23
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.98